Unknown

Dataset Information

0

Tumour purity as an underlying key factor in tumour mutation detection in colorectal cancer.

ABSTRACT:

SUBMITTER: Yu T 

PROVIDER: S-EPMC10154864 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Tumour purity as an underlying key factor in tumour mutation detection in colorectal cancer.

Yu Tao T   Huang Qianpeng Q   Zhao Xinyu X   Zhang Shiyao S   Zhang Qi Q   Fan Xingcan X   Liu Gang G  

Clinical and translational medicine 20230501 5

Similar Datasets

Unknown Biased Influences of Low Tumor Purity on Mutation Detection in Cancer.
| S-EPMC7785586 | biostudies-literature
Unknown Systematic pan-cancer analysis of tumour purity.
| S-EPMC4671203 | biostudies-literature
Unknown Gene Mutation Classification through Text Evidence Facilitating Cancer Tumour Detection.
| S-EPMC8337154 | biostudies-literature
Unknown Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer.
| S-EPMC10338477 | biostudies-literature
Unknown Soluble tumour necrosis factor receptor type II and survival in colorectal cancer.
| S-EPMC4984918 | biostudies-literature
Unknown Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha.
| S-EPMC4433886 | biostudies-literature
Unknown Integrated RNA and DNA sequencing improves mutation detection in low purity tumors.
| S-EPMC4117748 | biostudies-literature
Unknown Clinical significance of circulating tumour cells and tumour marker detection in the chemotherapeutic evaluation of advanced colorectal cancer.
| S-EPMC9298334 | biostudies-literature
Unknown Elastin is a key factor of tumor development in colorectal cancer.
| S-EPMC7071655 | biostudies-literature
Unknown Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution.
| S-EPMC5722928 | biostudies-literature